These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Levodopa delivery systems for the treatment of Parkinson's disease: an overview. Goole J; Amighi K Int J Pharm; 2009 Oct; 380(1-2):1-15. PubMed ID: 19651197 [TBL] [Abstract][Full Text] [Related]
25. CSF GABA levels in Parkinson's disease. de Jong PJ; Lakke JP; Teelken AW Adv Neurol; 1984; 40():427-30. PubMed ID: 6695622 [TBL] [Abstract][Full Text] [Related]
26. Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease. Liu B; Dluzen DE Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):555-65. PubMed ID: 17581209 [TBL] [Abstract][Full Text] [Related]
27. [Parkinson disease and the neuronal dopamine uptake complex]. Costentin J Ann Pharm Fr; 1995; 53(4):145-54. PubMed ID: 7574268 [TBL] [Abstract][Full Text] [Related]
28. The rationale for continuous dopaminergic stimulation in advanced Parkinson's disease. Nyholm D Parkinsonism Relat Disord; 2007 Sep; 13 Suppl():S13-7. PubMed ID: 17707679 [TBL] [Abstract][Full Text] [Related]
29. Mechanisms of Parkinson's disease. Br Med J; 1978 Apr; 1(6117):872-3. PubMed ID: 25109 [No Abstract] [Full Text] [Related]
30. Toxic effects of dopamine metabolism in Parkinson's disease. Hattoria N; Wanga M; Taka H; Fujimura T; Yoritaka A; Kubo S; Mochizuki H Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S35-8. PubMed ID: 19131041 [TBL] [Abstract][Full Text] [Related]
31. New insights in Parkinson's disease therapy: can levodopa-induced dyskinesia ever be manageable. Hadj Tahar A; Grondin R; Grégoire L; Calon F; Di Paolo T; Bédard PJ Adv Neurol; 2003; 91():51-64. PubMed ID: 12442663 [No Abstract] [Full Text] [Related]
32. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease. Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068 [TBL] [Abstract][Full Text] [Related]
33. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Evans AH; Katzenschlager R; Paviour D; O'Sullivan JD; Appel S; Lawrence AD; Lees AJ Mov Disord; 2004 Apr; 19(4):397-405. PubMed ID: 15077237 [TBL] [Abstract][Full Text] [Related]
34. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease. Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343 [TBL] [Abstract][Full Text] [Related]
35. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Cools R Neurosci Biobehav Rev; 2006; 30(1):1-23. PubMed ID: 15935475 [TBL] [Abstract][Full Text] [Related]
36. Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study. Sossi V; de la Fuente-Fernández R; Schulzer M; Troiano AR; Ruth TJ; Stoessl AJ Ann Neurol; 2007 Nov; 62(5):468-74. PubMed ID: 17886297 [TBL] [Abstract][Full Text] [Related]
37. Synaptic plasticity, dopamine and Parkinson's disease: one step ahead. Calabresi P; Mercuri NB; Di Filippo M Brain; 2009 Feb; 132(Pt 2):285-7. PubMed ID: 19168452 [No Abstract] [Full Text] [Related]
38. Reevaluation of levodopa therapy for the treatment of advanced Parkinson's disease. Yokochi M Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S25-30. PubMed ID: 19131038 [TBL] [Abstract][Full Text] [Related]
39. [Abnormalities of catecholamine metabolism in Parkinson's disease (author's transl)]. Nagatsu T Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1781-8. PubMed ID: 6117927 [No Abstract] [Full Text] [Related]
40. CNS dopamine oxidation and catechol-O-methyltransferase: importance in the etiology, pharmacotherapy, and dietary prevention of Parkinson's disease. Zhu BT Int J Mol Med; 2004 Mar; 13(3):343-53. PubMed ID: 14767563 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]